0001415889-24-017799.txt : 20240621
0001415889-24-017799.hdr.sgml : 20240621
20240621145700
ACCESSION NUMBER: 0001415889-24-017799
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240618
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pimblett Emily
CENTRAL INDEX KEY: 0001969365
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40708
FILM NUMBER: 241059750
MAIL ADDRESS:
STREET 1: C/O ELIEM THERAPEUTICS, INC.
STREET 2: 23515 NE NOVELTY HILL RD, STE B221 #125
CITY: REDMOND
STATE: WA
ZIP: 98053
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eliem Therapeutics, Inc.
CENTRAL INDEX KEY: 0001768446
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 832273741
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2801 CENTERVILLE ROAD 1ST FLOOR
STREET 2: PMB #117
CITY: WILMINGTON
STATE: DE
ZIP: 19808
BUSINESS PHONE: 877-354-3689
MAIL ADDRESS:
STREET 1: 2801 CENTERVILLE ROAD 1ST FLOOR
STREET 2: PMB #117
CITY: WILMINGTON
STATE: DE
ZIP: 19808
4
1
form4-06212024_060656.xml
X0508
4
2024-06-18
0001768446
Eliem Therapeutics, Inc.
ELYM
0001969365
Pimblett Emily
C/O ELIEM THERAPEUTICS, INC.
WILMINGTON
DE
19808
false
true
false
false
CHIEF ACCOUNTING OFFICER
0
Common Stock
2024-06-18
4
M
0
5000
A
5000
D
Common Stock
2024-06-20
4
S
0
1245
7.2145
D
3755
D
Restricted Stock Units
2024-06-18
4
M
0
5000
0
D
Common Stock
5000
35000
D
Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date.
/s/ William Cowles, Attorney-in-Fact
2024-06-21